Arcutis Biotherapeutics, Inc. (ARQT)
25.16
-0.13
(-0.51%)
USD |
NASDAQ |
Oct 02, 16:00
25.16
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Price : 25.16 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 25.64 | 25.78 | 25.01 | 25.16 | 1.778M |
| Oct 01, 2026 | 26.10 | 26.44 | 25.22 | 25.29 | 1.637M |
| Sep 30, 2026 | 27.00 | 27.39 | 26.41 | 26.43 | 2.391M |
| Sep 29, 2026 | 27.21 | 27.64 | 26.73 | 26.75 | 2.937M |
| Sep 28, 2026 | 26.70 | 27.55 | 26.43 | 27.33 | 3.066M |
| Sep 25, 2026 | 26.55 | 27.09 | 25.80 | 26.92 | 2.040M |
| Sep 24, 2026 | 26.22 | 26.68 | 25.19 | 26.27 | 2.178M |
| Sep 23, 2026 | 27.79 | 28.02 | 26.07 | 26.38 | 2.512M |
| Sep 22, 2026 | 25.90 | 28.29 | 25.69 | 27.78 | 2.858M |
| Sep 21, 2026 | 25.57 | 26.08 | 25.19 | 25.96 | 1.888M |
| Sep 18, 2026 | 26.14 | 26.75 | 25.13 | 25.38 | 19.14M |
| Sep 17, 2026 | 25.95 | 26.62 | 24.34 | 26.46 | 5.863M |
| Sep 16, 2026 | 23.63 | 26.39 | 23.63 | 26.14 | 5.156M |
| Sep 15, 2026 | 24.23 | 24.28 | 23.10 | 23.51 | 3.459M |
| Sep 14, 2026 | 23.79 | 24.75 | 23.79 | 24.27 | 2.032M |
| Sep 11, 2026 | 23.63 | 24.18 | 23.55 | 23.88 | 2.045M |
| Sep 10, 2026 | 23.70 | 23.84 | 23.25 | 23.38 | 1.785M |
| Sep 09, 2026 | 24.05 | 24.46 | 23.74 | 23.84 | 2.315M |
| Sep 08, 2026 | 24.84 | 25.13 | 24.09 | 24.39 | 4.560M |
| Sep 04, 2026 | 23.27 | 24.02 | 23.27 | 23.90 | 1.632M |
| Sep 03, 2026 | 24.13 | 24.13 | 23.47 | 23.66 | 1.122M |
| Sep 02, 2026 | 23.95 | 24.45 | 23.40 | 23.85 | 1.951M |
| Sep 01, 2026 | 23.79 | 24.11 | 23.54 | 23.75 | 1.102M |
| Aug 31, 2026 | 23.75 | 24.07 | 23.21 | 23.97 | 1.523M |
| Aug 28, 2026 | 24.60 | 24.88 | 23.74 | 23.78 | 1.536M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Insmed, Inc. | 111.12 |
| Emergent BioSolutions, Inc. | 6.33 |
| Exelixis, Inc. | 58.39 |
| Puma Biotechnology, Inc. | 9.51 |
Price Related Metrics
| PE Ratio | 121.49 |
| PS Ratio | 7.236 |
| Price to Book Value | 14.33 |
| Price to Free Cash Flow | 85.76 |
| Earnings Yield | 0.82% |
| Market Cap | 3.160B |
| Operating PE Ratio | 98.02 |
| Normalized PE Ratio | 121.25 |